
It takes effort to embrace complexity. Simple models, simple narratives seem easier up front, their consequences only obvious in retrospect. When we talk about COVID-19 transmission rates, we’re using averages that do not offer crucial insights into how those rates may vary. When we target complex ailments with silver-bullet pharmaceuticals, we don’t address the underlying systems-level…